Bioprocessing Systems Market Size, Share and Forecast, 2032

What is the projected value for the Bioprocessing Systems Market during 2024 to 2032?

According to the report published by Zion Market Research, the global Bioprocessing Systems Market size was valued at USD 220.31 Million in 2023 and is predicted to reach USD 1,328.85 Million by the end of 2032. The market is expected to grow with a CAGR of 22.10% during the forecast period. The report analyzes the global Bioprocessing Systems Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Bioprocessing Systems Market industry.

Request Free SampleRequest Free Sample

Global Bioprocessing Systems Market: Overview

For the manufacturing of the biologics there is a requirement of the complicated process and thus the manufacturers prefer outsourcing it. Bioprocessing is the process which helps in the manufacturing of the bio-based products which includes fatty acids and vegetable oils. The major applications where the bioprocess systems are used include vaccines, biosensors, tissue engineering, and biopharmaceuticals.

Key Insights

• As per the analysis shared by our research analyst, the global Bioprocessing Systems Market is estimated to grow annually at a CAGR of around 22.10% over the forecast period (2024-2032).
• In terms of revenue, the global Bioprocessing Systems Market size was valued at around USD 220.31 Million in 2023 and is projected to reach USD 1,328.85 Million by 2032.
• Based on the process, The upstream bioprocessing segment dominates the bioprocessing systems market. This dominance is attributed to the critical role upstream processes play in determining the efficiency and yield of biopharmaceutical production. It includes key steps like cell culture, media preparation, and fermentation, which are fundamental for achieving high product quality and volume, especially in the production of monoclonal antibodies, vaccines, and other biologics.
• Based on the applications, Among the applications, vaccine development holds the leading position. This is largely due to the rising demand for vaccines globally, especially following the COVID-19 pandemic, which accelerated investments and advancements in vaccine R&D and manufacturing. The need for large-scale production and stringent regulatory compliance has driven pharmaceutical companies to adopt advanced bioprocessing systems.
• Based on the end-user, The biopharmaceutical companies segment is the most dominant end-user in the market. These companies are the primary adopters of bioprocessing technologies, utilizing them extensively for the development and manufacturing of complex biologics. Their continuous investment in R&D, expansion of production capabilities, and growing biologics pipeline contribute significantly to this segment's market share.
• Based on the region, North America emerges as the dominant regional segment in the bioprocessing systems market. The region’s leadership is supported by a well-established biopharmaceutical industry, strong presence of major market players, advanced healthcare infrastructure, and substantial investment in biotechnology research. The U.S., in particular, plays a pivotal role in driving regional growth through continuous innovation and favorable government support.

Global Bioprocessing Systems Market: Growth Factors

The key factor that is fuelling the growth of the global bioprocessing systems market is the growing demand for the products that are bio based. There is a growing demand for the bioprocessing systems in the industries such as pharmaceuticals, chemicals, food, nutraceuticals, and polymers. The increasing rate of the automation in various industrial processes has decreased the rate of human errors thus triggering the growth of the bioprocessing systems market. The other factors that are fuelling the growth of the market are the increasing requirement for the biopharmaceutical production, the rise in the occurrences of the chronic diseases, low manufacturing costs when compared with the artificial supply of the materials, and the advancements that are made in the infrastructure.

Global Bioprocessing Systems Market: Report Scope

Global Bioprocessing Systems Market: Segmentation

Request Free SampleRequest Free Sample

The global market for the bioprocessing systems is fragmented into its process, applications, and end-user industries. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

On the basis of process, the global market for the bioprocessing system is segregated into downstream, integrated, upstream, and single use.

On the basis of application, the market is categorized into cell therapy and plant cell cultivation, tissue engineering, bioreactors and mixers, chromatography, environmental management aid, vaccine development, filters, biosensors, plasma fractionation, and bio-therapeutic molecule production.

On the basis of end-user industries, the market is divided into specialty products and industrial chemicals, biopharmaceutical, food and beverages, and nutraceuticals.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Global Bioprocessing Systems Market: Regional Analysis

Request Free SampleRequest Free Sample

According to the regional study, the global market for the balanced salt solution for cell culture is diversified into Eastern Europe, North America, Asia Pacific, Latin America, Western Europe, and the Middle East and Africa. The regions that are currently contributing a good share in the bioprocessing market are Europe and North America. The factors that are contributing to the market growth in these regions are the growing demand for the nutraceutical and the biopharmaceutical industries and increased applications such as in life sciences, food and beverages, and others.

The market in Asia Pacific region is also growing at a good rate owing to the factors such as the rapid economic development, rise in the use of the industrial chemicals in the nutraceutical industries, and the huge demand for the products that are bio based in the food and beverage sector. As the potential market players are investing in this region for the market development thus it is expected that the market will grow in the Asia Pacific region in the coming years.

Global Bioprocessing Systems Market: Competitive Players

The key market players that are involved in the bioprocessing systems include:

• Pall Corporation
• Nordson Medical's
• Thermo Fisher Scientific Inc.
• PBS Biotech, Inc.
• Lonza
• GE Healthcare Bio-Sciences AB
• Robert Bosch GmbH.
• EMD Millipore Corporation.

Global Bioprocessing Systems Market: Segmentation Analysis

The Global Bioprocessing Systems Market is segmented as follows:

By Process 

• Downstream 
• Integrated 
• Upstream 
• Single Use 

By Applications 

• Cell Therapy And Plant Cell Cultivation 
• Tissue Engineering 
• Bioreactors And Mixers 
• Chromatography 
• Environmental Management Aid
• Vaccine Development 
• Filters 
• Biosensors 
• Plasma Fractionation
• Bio-therapeutic Molecule Production

By End-user 

• Specialty Products 
• Industrial Chemicals 
• Biopharmaceutical 
• Food And Beverages 
• Nutraceuticals

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.